• Video
  • Shop
  • Culture
  • Family
  • Wellness
  • Food
  • Living
  • Style
  • Travel
  • News
  • Book Club
  • Newsletter
  • Privacy Policy
  • Your US State Privacy Rights
  • Children's Online Privacy Policy
  • Interest-Based Ads
  • Terms of Use
  • Your Privacy Choices
  • Contact Us
  • Recalls and Product Safety Alerts
  • © 2026 ABC News
  • News

Calcium Channel Blockers Not Best for Hypertension

ByGood Morning America
December 08, 2000, 2:10 PM

L O N D O N, Dec. 8 -- Calcium channel blockers, populardrugs used to lower high blood pressure, are not as effective asother treatments, researchers said today.

Two reviews of studies assessing blood pressure drugs,published in The Lancet medical journal, showed people treatedwith calcium channel blockers (CCBs) were more likely to suffera heart attack or other complications.

“In an analysis of more than 27,000 patients with high bloodpressure, we found that those treated with CCBs had a 26 percenthigher risk of heart attack and a 25 percent higher risk ofheart failure than those treated with other drugs,” saidProfessor Marco Pahor.

Better Than Nothing

CCBs were more effective than no treatment, but the risk ofall heart problems — heart attacks, stroke, heart failure anddeath from heart disease — was 10 percent higher in patientstreated with CCBs.

“These results show that CCBs are less effective than thestandard drugs used to treat high blood pressure,” Pahor, ofWake Forest University Baptist Medical Center in North Carolina,added.

CCBs, which are also known as calcium antagonists, work byinhibiting the passage of calcium, an important element formuscle contraction, into cells of the heart and muscle fibers ofblood vessels.

The researchers compared the effects of CCBs to diuretics orwater pills, and beta-blockers and ACE (angiotension convertingenzyme) inhibitors.

The review of nine studies showed CCBs were just as good asthe other treatment in lowering blood pressure but not aseffective in preventing complications such as heart attacks andheart failure.

Limited Use of CCBs

“These data reinforce the view that use of CCBs should belimited to patients who do not tolerate, or who have failed ondiuretics, beta blockers or ACE inhibitors,” said Dr WilliamApplegate, a co-author of the study.

The findings were supported by another overview byresearchers in Australia. It showed CCBs decreased the risk ofstroke but did not significantly reduce cases of heart disease,heart failure and deaths.

Up Next in News—

New report looks at how AI is impacting trust between students and teachers

September 30, 2026

Lindsay Clancy's attorney says there's no evidence she killed her children in 1st hearing since mistrial

September 29, 2026

E. coli outbreak linked to raw milk cheese brand: CDC, FDA

September 26, 2026

Judge in Lindsay Clancy case indefinitely impounds jury questionnaires

September 23, 2026

Shop GMA Favorites

ABC will receive a commission for purchases made through these links.

Sponsored Content by Taboola

The latest lifestyle and entertainment news and inspiration for how to live your best life - all from Good Morning America.
  • Contests
  • Terms of Use
  • Privacy Policy
  • Your Privacy Choices
  • Children’s Online Privacy Policy
  • Advertise with us
  • Your US State Privacy Rights
  • Interest-Based Ads
  • About Nielsen Measurement
  • Press
  • Feedback
  • Shop FAQs
  • ABC News
  • ABC
  • All Videos
  • All Topics
  • Sitemap
  • Recalls and Product Safety Alerts

© 2026 ABC News
  • Privacy Policy— 
  • Your US State Privacy Rights— 
  • Children's Online Privacy Policy— 
  • Interest-Based Ads— 
  • Terms of Use— 
  • Your Privacy Choices— 
  • Contact Us— 
  • Recalls and Product Safety Alerts— 

© 2026 ABC News